Morikawa T, Yoshida M
Pharmaceutical Development Division, Takeda Chemical Industries, Ltd, Osaka, Japan.
J Biopharm Stat. 1995 Nov;5(3):297-306. doi: 10.1080/10543409508835115.
A useful testing strategy is proposed for a confirmatory phase III clinical trial. It consists of a combined test of superiority and test of equivalence, and it is easy to apply. By introducing the strategy, we can perform a post hoc analysis in a confirmatory experiment. Thus a more flexible decision will be possible than the usual single testing method provides. It is shown that the procedure needs no adjustment for multiplicity from the point of view of the closed testing procedure. The relationship between this strategy and a confidence interval is also discussed.
针对确证性III期临床试验,提出了一种实用的测试策略。它由优效性联合检验和等效性检验组成,且易于应用。通过引入该策略,我们可以在确证性实验中进行事后分析。因此,与通常的单一测试方法相比,将有可能做出更灵活的决策。结果表明,从封闭检验程序的角度来看,该程序无需对多重性进行调整。还讨论了此策略与置信区间之间的关系。